Efficacy and Safety of Tofacitinib in Refractory Blau Syndrome
Efficacy and Safety of Tofacitinib in Refractory Blau Syndrome
Enrolling by invitation · NCT06660329 · Registry updated 2024-10-28Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Efficacy and Safety of Tofacitinib in Refractory Blau Syndrome | Blau syndrome | Enrolling by invitation | Phase 4 | 2024-10-28 | NCT06660329 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Peking Union Medical College Hospital | 417 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Peking Union Medical College Hospital | Beijing | China | 62 |